70 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
31,
Year Ended
December 31,
Year Ended
December 31,
Operating expenses:
Research and development
Selling, general, and administrative
Total … research and development, manufacturing, conducting clinical trials for its product candidates, protecting its intellectual property and general
8-K
EX-99.1
epkanra6jwc
9 Aug 18
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:07pm
10-Q
ujypdfn 3ypk17x
14 Nov 17
Quarterly report
12:00am
8-K
EX-99.1
7jt j2id0ty
9 Nov 18
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
12:40pm